Innovation Pharma’s COVID-19 Drug Candidate Brilacidin Ranked in Top Three Percent of Compounds Predicted to Be Most Effective Against SARS-CoV-2

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement